November 1, 2018
Magenta Therapeutics Announces Acceptance of Nine Abstracts Covering Clinical and Preclinical Data at ASH, Representing Progress across the Portfolio of Conditioning, Stem Cell Mobilization and Expansion Programs
September 24, 2018
Magenta Therapeutics Added to Russell 2000 and 3000 Indexes
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Magenta disavows any obligation to update the information contained in such press releases after the date of their issuance.